Heart valve repair for severe leaking tricuspid valve
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests a catheter-based procedure (done through the blood vessels) to repair a severely leaky tricuspid valve. It may help people with symptoms or past hospitalizations from tricuspid valve leakage who are higher-risk for standard surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have severe (or worse) tricuspid valve leakage causing symptoms or a heart-failure hospitalization
- Your heart team believes you have at least moderate surgical risk for tricuspid valve surgery
- An ultrasound of your heart (echo) can show enough tricuspid valve anatomy for the device to work
- You are able and willing to sign consent and attend required follow-up visits
- You do not have certain recent heart procedures, infections, clots, or major valve problems that block participation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This trial studies a catheter-based repair to help fix a leaky tricuspid valve (regurgitation), especially when you’re also having another heart surgery. It aims to improve valve function and symptoms while tracking safety and outcomes.
This trial tests a new device called the Laplace system, which replaces the tricuspid valve in your heart without open-heart surgery. It is designed for people with severe tricuspid regurgitation (a leaky heart valve) who still have symptoms despite taking medications.
This trial tests a new device called TricValve, which is placed through a catheter (a thin tube) to fix a leaky tricuspid valve on the right side of the heart. It aims to reduce blood flowing backward and improve heart failure symptoms for people who can't have open-heart surgery and haven't been helped by other catheter treatments.
This trial tests a procedure that uses a small clip to fix a leaky tricuspid valve in the heart. The goal is to reduce symptoms like shortness of breath and fatigue, and help you feel better in your daily life.
This trial studies a new valve replacement device (the Cor TRICUSPID ECM Valve) for people whose right-sided tricuspid valve is leaking or missing and needs surgery. It may help restore proper one-way blood flow in the heart, but you must meet several heart, blood, and organ-health requirements.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.